Who Is An Ideal Candidate For Wavelight Plus InnovEyes?

What Makes Wavelight Plus InnovEyes Different From Standard LASIK

Wavelight Plus InnovEyes is a Contoura Vision-based laser eye correction system that goes beyond standard LASIK in one fundamental way: rather than correcting your eye based on your prescription and a population-average corneal model, it builds a personalised 3D digital twin of your specific eye — the eyevatar — using integrated diagnostic data from the InnovEyes Sightmap device. This model captures corneal topography, wavefront aberrations, and biometric measurements simultaneously, and feeds them into an AI-driven treatment plan that is unique to your eye. A complete overview of what Wavelight Plus InnovEyes is and how it works provides the full clinical context for patients who are at the research stage.

The practical consequence of this level of personalisation is that patients with complex visual complaints — particularly those whose best spectacle correction still left them with glare, poor contrast, or night vision problems — often achieve outcomes that standard procedures cannot replicate. 98% of patients achieve 6/6 vision or better; a meaningful subset reach 6/5 or the “Eagle Eye” level of 6/4. But those outcomes depend on the right patient sitting in the treatment chair — which is why candidacy assessment is not a formality.

8 Characteristics of an Ideal Candidate

1. Prescription Stable for at Least 12 Months

Prescription stability is the foundation of every laser refractive procedure — but it carries particular weight for Wavelight Plus InnovEyes because the eyevatar is built from your current corneal measurements. If your prescription is still changing when the eyevatar is created, the surgical plan is based on a moving target. Most surgeons require documented stability over a minimum of 12 consecutive months; 18–24 months of unchanged prescription is a stronger baseline. Patients under 21 warrant careful stability assessment before proceeding, as refractive errors frequently continue to develop into the early twenties.

2. Adequate Corneal Thickness and Healthy Corneal Structure

Because Wavelight Plus InnovEyes creates a corneal flap before ablating the underlying stroma, the procedure requires sufficient thickness to safely accommodate both the flap and the prescription-correcting ablation while leaving a minimum residual stromal bed of 250 microns. Standard pre-operative corneal mapping determines this precisely. Patients with thin or structurally irregular corneas — particularly those with subclinical keratoconus patterns on topography — face elevated ectasia risk and are generally not appropriate candidates for any flap-based procedure. Our dedicated clinical guide on whether Wavelight Plus InnovEyes is suitable for thin corneas explains precisely where the safe threshold sits and what the diagnostic assessment reveals for borderline patients.

3. Measurable Higher-Order Aberrations

Wavelight Plus InnovEyes’ most distinctive advantage is the correction of higher-order aberrations — optical imperfections beyond sphere and cylinder that standard laser procedures cannot address. These include coma, trefoil, spherical aberration, and others that manifest as glare, halos, reduced contrast sensitivity, and poor night vision. Patients who test positive for significant higher-order aberrations on wavefront mapping are the group who gain the most clinically distinctive benefit from this procedure. Patients with clean, uncomplicated wavefront profiles still achieve excellent results — but with less differentiation from standard well-validated alternatives.

4. Desire for Exceptional Visual Outcomes

Wavelight Plus InnovEyes attracts a specific patient profile: professionals, athletes, and individuals whose visual performance requirements go meaningfully beyond the 6/6 standard. Pilots, surgeons, architects, professional drivers, and competitive athletes in precision sports consistently describe post-operative visual quality that exceeds what their best glasses or contact lenses ever delivered. The outcomes data backs this up — our dedicated page on the success rate of Wavelight Plus InnovEyes details what percentage of patients achieve 6/6, 6/5, and Eagle Eye 6/4 levels of acuity — and what drives those differences between patients.

5. Age 18 or Older With Stable Eye Development

Most refractive surgeons require candidates to be at least 18 years old before undergoing Wavelight Plus InnovEyes. This threshold reflects the reality that younger eyes are often still developing, and a correction based on today’s measurements may not remain optimal as the prescription continues to evolve. There is no upper age limit as a general rule — patients in their forties, fifties, and beyond can be excellent candidates provided their eye health meets the required standards. However, older adults developing cataracts require separate assessment, as the cataract rather than the cornea becomes the primary optical issue at that stage.

6. No Active Pre-Existing Eye Disease

Several eye conditions are absolute contraindications to Wavelight Plus InnovEyes — not because the technology is flawed, but because the underlying condition must be resolved before any refractive surgery makes clinical sense:

• Keratoconus: Progressive corneal thinning and irregularity creates both an ectasia risk and an unstable optical surface that no laser plan can reliably correct.
• Glaucoma: Elevated intraocular pressure and optic nerve involvement require dedicated management. Refractive surgery does not address glaucoma and can complicate its subsequent measurement.
• Significant cataracts: When the crystalline lens has become the primary optical compromise, lens replacement surgery rather than corneal reshaping is the appropriate intervention.
• Severe dry eye: Flap-based procedures significantly worsen dry eye because flap creation severs more corneal nerves than flapless alternatives. Patients with significant pre-existing dry eye are better served by flapless options where the nerve disruption is lower.

7. Realistic Expectations About Outcomes and Ageing

Wavelight Plus InnovEyes corrects your refractive error — it does not halt the natural ageing of the eye. Presbyopia, the gradual loss of near-focus ability that affects most people from their mid-forties, will still develop after surgery regardless of how well the distance correction performs. Some patients ask whether Wavelight Plus InnovEyes can address presbyopia — our page on whether Wavelight Plus InnovEyes can correct presbyopia explains what the procedure can and cannot address for age-related near vision loss, which is clinically important for patients over 40 to understand before making a decision. Patients who understand this distinction before surgery consistently report higher satisfaction at the 12-month mark than those who expected the procedure to permanently preserve all aspects of their vision indefinitely.

8. Good General Health and Normal Healing Capacity

Conditions that impair wound healing — uncontrolled diabetes, autoimmune disorders, immunosuppressive medications — can compromise post-operative recovery and increase infection risk. These are not universal disqualifiers, but they require careful pre-operative evaluation and honest disclosure. Patients on systemic medications that affect corneal healing or tear film production should discuss their full medication list with the surgeon during the assessment, not just their eye-specific history.

Who Is Not a Good Candidate — And Why

The conditions that disqualify a patient from Wavelight Plus InnovEyes fall into three broad categories. First, patients with corneal contraindications — thin corneas, irregular topography, confirmed or suspected keratoconus — where the flap-based architecture creates ectasia risk that cannot be safely managed. Second, patients with active ocular disease that must be treated first: glaucoma, significant cataracts, severe dry eye, or retinal pathology. Third, patients with lifestyle or anatomical profiles where a flapless alternative is clinically preferable — active contact sport participants, those in professions with elevated eye trauma risk, or patients who cannot rule out future blunt eye trauma. For a complete clinical picture of all potential complications and who faces elevated risk, our detailed guide to the potential risks and side effects of Wavelight Plus InnovEyes is essential reading before your consultation.

None of these groups is without good surgical options. They simply need a different procedure — and in most cases, the same pre-operative assessment that confirms ineligibility for Wavelight Plus InnovEyes also identifies which alternative is most appropriate.

The Flap-Based Factor — A Key Decision Point

It is worth being explicit about this aspect of Wavelight Plus InnovEyes, because patients comparing it to SMILE Pro often ask why the Wavelight system retains a corneal flap given the known advantages of flapless design. The answer is that the flap architecture allows a specific category of correction — wavefront-guided ablation of the anterior stroma with InnovEyes precision — that the current flapless lenticule extraction technique cannot replicate at the same level of aberration specificity for complex cases.

For patients with complex higher-order aberrations, the trade-off can be worth it. For patients with straightforward prescriptions, normal wavefront profiles, and/or corneal anatomy that makes the flap a limiting factor, SMILE Pro typically represents a better clinical choice. Our comparison guide on Wavelight Plus InnovEyes versus SMILE Pro gives a direct head-to-head breakdown across every key clinical dimension — helping patients who are genuinely deciding between both procedures understand exactly which profile benefits most from each.

How Candidacy Is Determined at Visual Aids Centre

The candidacy assessment for Wavelight Plus InnovEyes at Visual Aids Centre uses the InnovEyes Sightmap device itself — meaning the most accurate corneal measurement available is used to make the candidacy determination, not a separate and potentially less precise screening tool. This has a practical benefit for borderline patients: those whose standard topography placed them in an uncertain zone sometimes find that Sightmap’s posterior surface measurement confirms them as suitable candidates.

The assessment also includes a full refraction measurement, pupil size evaluation in scotopic conditions, tear film quality assessment, and a review of ocular and systemic health history. The combined picture — not any single parameter — determines the clinical recommendation. Patients who are found not to be Wavelight Plus InnovEyes candidates leave the assessment with a clear understanding of why, and a clinically-grounded recommendation for the most appropriate alternative. Our guide to the pre-surgery evaluations required before Wavelight Plus InnovEyes covers every test involved and why each one matters for the candidacy determination.